Toru Hiruma

2.1k total citations
46 papers, 1.4k citations indexed

About

Toru Hiruma is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Toru Hiruma has authored 46 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 14 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Toru Hiruma's work include Sarcoma Diagnosis and Treatment (25 papers), Glycosylation and Glycoproteins Research (10 papers) and Carbohydrate Chemistry and Synthesis (8 papers). Toru Hiruma is often cited by papers focused on Sarcoma Diagnosis and Treatment (25 papers), Glycosylation and Glycoproteins Research (10 papers) and Carbohydrate Chemistry and Synthesis (8 papers). Toru Hiruma collaborates with scholars based in Japan, United States and Saudi Arabia. Toru Hiruma's co-authors include Hisashi Narimatsu, Takashi Kudo, Akira Togayachi, Akira Kawai, Hiroko Iwasaki, Hideo Morioka, Toshie Iwai, Kouichi Tachibana, Tsukasa Yonemoto and Masanori Gotoh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Toru Hiruma

43 papers receiving 1.3k citations

Peers

Toru Hiruma
Toru Hiruma
Citations per year, relative to Toru Hiruma Toru Hiruma (= 1×) peers Emir Hadzijusufovic

Countries citing papers authored by Toru Hiruma

Since Specialization
Citations

This map shows the geographic impact of Toru Hiruma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toru Hiruma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toru Hiruma more than expected).

Fields of papers citing papers by Toru Hiruma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toru Hiruma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toru Hiruma. The network helps show where Toru Hiruma may publish in the future.

Co-authorship network of co-authors of Toru Hiruma

This figure shows the co-authorship network connecting the top 25 collaborators of Toru Hiruma. A scholar is included among the top collaborators of Toru Hiruma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toru Hiruma. Toru Hiruma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sato, Shinya, Toru Hiruma, Mitsuyo Yoshihara, et al.. (2023). Bone marrow adipocytes induce cancer‐associated fibroblasts and immune evasion, enhancing invasion and drug resistance. Cancer Science. 114(6). 2674–2688. 17 indexed citations
2.
Washimi, Kota, Yukihiko Hiroshima, Rika Kasajima, et al.. (2023). Differential diagnosis of uterine adenosarcoma: identification of JAZF1-BCORL1 rearrangement by comprehensive cancer genomic profiling. Diagnostic Pathology. 18(1). 5–5. 3 indexed citations
3.
4.
Urakawa, Hiroshi, Akihito Nagano, Ryunosuke Machida, et al.. (2022). A randomized phase III trial of denosumab before curettage for giant cell tumor of bone. JCOG1610. Japanese Journal of Clinical Oncology. 52(9). 1021–1028. 3 indexed citations
5.
Kato, Shingo, Yusuke Kawabata, Ikuma Kato, et al.. (2022). Effect of Tranilast on the Frequency of Invasive Treatment for Extra-Abdominal Desmoid Fibromatosis. Journal of Nippon Medical School. 90(1). 79–88. 3 indexed citations
6.
Washimi, Kota, Shinya Sato, Toru Hiruma, et al.. (2022). Differential diagnosis of lipoma and atypical lipomatous tumor/well‐differentiated liposarcoma by cytological analysis. Diagnostic Cytopathology. 50(3). 112–122. 9 indexed citations
7.
Hagiwara, Yoko, Shintaro Iwata, Koichi Ogura, et al.. (2021). Clinical analysis of multimodal treatment for localized synovial sarcoma: A multicenter retrospective study. Journal of Orthopaedic Science. 28(1). 261–266. 3 indexed citations
8.
Endo, Makoto, Shunji Takahashi, Nobuhito Araki, et al.. (2020). Time lapse analysis of tumor response in patients with soft tissue sarcoma treated with trabectedin: A pooled analysis of two phase II clinical trials. Cancer Medicine. 9(11). 3656–3667. 7 indexed citations
9.
Таnака, К., Junki Mizusawa, Haruhiko Fukuda, et al.. (2015). Perioperative chemotherapy with ifosfamide and doxorubicin for high-grade soft tissue sarcomas in the extremities (JCOG0304). Japanese Journal of Clinical Oncology. 45(6). 555–61. 42 indexed citations
10.
Gharanei, Seley, A.T. Brini, Sumathi Vaiyapuri, et al.. (2013). RASSF2methylation is a strong prognostic marker in younger age patients with Ewing sarcoma. Epigenetics. 8(9). 893–898. 24 indexed citations
11.
Iwata, Shintaro, Takeshi Ishii, Akira Kawai, et al.. (2013). Prognostic Factors in Elderly Osteosarcoma Patients: A Multi-institutional Retrospective Study of 86 Cases. Annals of Surgical Oncology. 21(1). 263–268. 56 indexed citations
12.
Brini, A.T., Seley Gharanei, Sumathi Vaiyapuri, et al.. (2013). Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma. Epigenetics. 8(11). 1198–1204. 36 indexed citations
13.
Sugiura, Hideshi, Yasuhiro Fujiwara, Masashi Ando, et al.. (2010). Multicenter Phase II trial assessing effectiveness of imatinib mesylate on relapsed or refractory KIT-positive or PDGFR-positive sarcoma. Journal of Orthopaedic Science. 15(5). 654–660. 23 indexed citations
14.
Kudo, Takashi, Toshie Iwai, Tomomi Kubota, et al.. (2006). Molecular cloning and characterization of a novel UDP-Gal:GalNAcα peptide β1,3-galactosyltransferase (C1Gal-T2), an enzyme synthesizing a core 1 structure of O-glycan. VOLUME 277 (2002) PAGES 47724-47731. Journal of Biological Chemistry. 281(34). 24999–24999. 2 indexed citations
15.
Tachibana, Kouichi, et al.. (2004). 新規なヒトUDP-GalNAcトランスフェラーゼpp-GalNAc-T15の特性化. FEBS Letters. 566. 17–24. 40 indexed citations
16.
Cheng, Lamei, Kouichi Tachibana, Hiroko Iwasaki, et al.. (2004). Characterization of a novel human UDP‐GalNAc transferase, pp‐GalNAc‐T15. FEBS Letters. 566(1-3). 17–24. 58 indexed citations
17.
Mochizuki, Hideo, Keiichi Yoshida, Masanori Gotoh, et al.. (2003). Characterization of a Heparan Sulfate 3-O-Sulfotransferase-5, an Enzyme Synthesizing a Tetrasulfated Disaccharide. Journal of Biological Chemistry. 278(29). 26780–26787. 58 indexed citations
18.
Cheng, Lamei, Kouichi Tachibana, Yan Zhang, et al.. (2002). Characterization of a novel human UDP‐GalNAc transferase, pp‐GalNAc‐T101. FEBS Letters. 531(2). 115–121. 92 indexed citations
19.
Kudo, Takashi, Toshie Iwai, Tomomi Kubota, et al.. (2002). Molecular Cloning and Characterization of a Novel UDP-Gal:GalNAcα Peptide β1,3-Galactosyltransferase (C1Gal-T2), an Enzyme Synthesizing a Core 1 Structure of O-Glycan. Journal of Biological Chemistry. 277(49). 47724–47731. 62 indexed citations
20.
Machida, Jiro, Tomihisa Koshino, Nobuyuki Yoshida, et al.. (1995). Establishment of Two Rat Osteosarcoma Cell Lines (YROS-1 and YROS-2) Induced by Radioactive Phosphorus. Pathology - Research and Practice. 191(5). 478–485. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026